Clinical Trial: Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
Clinical Trial: Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
Sponsor and Collaborators University of British Columbia Genzyme Contact Contact: Jessica McAlpine, MD 604 877-6000 [email protected]
Principal Investigator Study Director: Dr. Dianne Miller British Columbia Cancer Agency Study Director: Mark S Carey, MD University of British Columbia Study Director: Thomas G Ehlen, MD University of British Columbia Principal Investigator: Sarah Finlayson, MD University of British Columbia Study Director: Janice Kwon, MD University of British Columbia Study Director: Gavin CE Stuart, MD University of British Columbia Study Director: Anna Tinker, MD British Columbia Cancer Agency Study Director: Mark Heywood, MD University of British Columbia ClinicalTrials.gov Identifier NCT01095367
Enjoying our content?
Thanks for visiting Oncology Nurse Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.